FBCG | IVW | FBCG / IVW | |
Gain YTD | 11.046 | 14.501 | 76% |
Net Assets | 4.7B | 63.8B | 7% |
Total Expense Ratio | 0.59 | 0.18 | 328% |
Turnover | 42.00 | 31.00 | 135% |
Yield | 0.11 | 0.44 | 25% |
Fund Existence | 5 years | 25 years | - |
FBCG | IVW | |
---|---|---|
RSI ODDS (%) | 1 day ago87% | 4 days ago72% |
Stochastic ODDS (%) | 1 day ago76% | 1 day ago78% |
Momentum ODDS (%) | 1 day ago86% | 1 day ago90% |
MACD ODDS (%) | 1 day ago90% | N/A |
TrendWeek ODDS (%) | 1 day ago82% | 1 day ago76% |
TrendMonth ODDS (%) | 1 day ago89% | 1 day ago88% |
Advances ODDS (%) | 3 days ago89% | 3 days ago87% |
Declines ODDS (%) | 5 days ago85% | 5 days ago78% |
BollingerBands ODDS (%) | 1 day ago82% | 1 day ago80% |
Aroon ODDS (%) | 1 day ago90% | 1 day ago89% |
A.I.dvisor indicates that over the last year, FBCG has been closely correlated with NVDA. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if FBCG jumps, then NVDA could also see price increases.
Ticker / NAME | Correlation To FBCG | 1D Price Change % | ||
---|---|---|---|---|
FBCG | 100% | -0.58% | ||
NVDA - FBCG | 83% Closely correlated | -2.70% | ||
AMZN - FBCG | 81% Closely correlated | -1.42% | ||
META - FBCG | 79% Closely correlated | +0.51% | ||
ARES - FBCG | 78% Closely correlated | -1.52% | ||
ETN - FBCG | 78% Closely correlated | +0.23% | ||
More |
A.I.dvisor indicates that over the last year, IVW has been closely correlated with NVDA. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVW jumps, then NVDA could also see price increases.
Ticker / NAME | Correlation To IVW | 1D Price Change % | ||
---|---|---|---|---|
IVW | 100% | -0.09% | ||
NVDA - IVW | 82% Closely correlated | -2.70% | ||
AMZN - IVW | 78% Closely correlated | -1.42% | ||
ETN - IVW | 78% Closely correlated | +0.23% | ||
PH - IVW | 78% Closely correlated | +0.21% | ||
META - IVW | 78% Closely correlated | +0.51% | ||
More |